New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study finds Black patients wait longer for uterine cancer testing, diagnosis

Study finds Black patients wait longer for uterine cancer testing, diagnosis

by Mallory Locklear,Yale UniversityCredit: Unsplash/CC0 Public DomainEarly diagnosis of uterine cancer is known to improve a patient's chances for survival, but previous research has found t
Oncology February 18,2024
Study finds Black patients wait longer for uterine cancer testing, diagnosis

Study finds Black patients wait longer for uterine cancer testing, diagnosis

by Mallory Locklear,Yale UniversityCredit: Unsplash/CC0 Public DomainEarly diagnosis of uterine cancer is known to improve a patient's chances for survival, but previous research has found t
Oncology February 18,2024
First-in-class targeted microRNA therapy slows cancer tumor growth

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de
Oncology February 18,2024
First-in-class targeted microRNA therapy slows cancer tumor growth

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de
Oncology February 18,2024
Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th
Oncology February 18,2024
Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th
Oncology February 18,2024
A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa
Oncology February 18,2024
A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa
Oncology February 18,2024
Genetically engineered bacteria can detect cancer cells in a world-first experiment

Genetically engineered bacteria can detect cancer cells in a world-first experiment

by Dan Worthley,The ConversationCredit: AI-generated imageAs medical technology advances, many diseases could be detected, prevented and cured with cells, rather than pills.This branch of medici
Oncology February 18,2024
Genetically engineered bacteria can detect cancer cells in a world-first experiment

Genetically engineered bacteria can detect cancer cells in a world-first experiment

by Dan Worthley,The ConversationCredit: AI-generated imageAs medical technology advances, many diseases could be detected, prevented and cured with cells, rather than pills.This branch of medici
Oncology February 18,2024
Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer

Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer

by The Spanish National Cancer Research CentreClinical trial tumor samples: the phosphoprofiles were independent of the study site and/or treatment arm.AClinical trial treatment and s
Oncology February 18,2024
Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer

Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer

by The Spanish National Cancer Research CentreClinical trial tumor samples: the phosphoprofiles were independent of the study site and/or treatment arm.AClinical trial treatment and s
Oncology February 18,2024
Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians connect a re-entry
Oncology February 18,2024
Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians connect a re-entry
Oncology February 18,2024
Researchers identify women with twice the risk of cancer in both breasts

Researchers identify women with twice the risk of cancer in both breasts

by Mayo ClinicCumulative incidence of CBC risk in PV carriers. Cumulative incidence plots for first contralateral breast cancers after primary breast cancer. Cumulative incidence is plotted again
Oncology February 18,2024
Researchers identify women with twice the risk of cancer in both breasts

Researchers identify women with twice the risk of cancer in both breasts

by Mayo ClinicCumulative incidence of CBC risk in PV carriers. Cumulative incidence plots for first contralateral breast cancers after primary breast cancer. Cumulative incidence is plotted again
Oncology February 18,2024
Researchers 3D bioprint breast cancer tumors, treat them in new study

Researchers 3D bioprint breast cancer tumors, treat them in new study

by Adrienne Berard,Pennsylvania State UniversityA scanning electron microscopy image shows a breast cancer cell (cyan) being attacked by T cells (red), which were engineered to recognize the can
Oncology February 18,2024
Researchers 3D bioprint breast cancer tumors, treat them in new study

Researchers 3D bioprint breast cancer tumors, treat them in new study

by Adrienne Berard,Pennsylvania State UniversityA scanning electron microscopy image shows a breast cancer cell (cyan) being attacked by T cells (red), which were engineered to recognize the can
Oncology February 18,2024
Increasing level of alcohol intake may raise risk for cancer

Increasing level of alcohol intake may raise risk for cancer

Adults who increase their alcohol consumption may have a higher risk for alcohol-related cancers and all cancers versus adults who had sustained quitting or reduced levels of drinking, according to a
Oncology February 18,2024
Increasing level of alcohol intake may raise risk for cancer

Increasing level of alcohol intake may raise risk for cancer

Adults who increase their alcohol consumption may have a higher risk for alcohol-related cancers and all cancers versus adults who had sustained quitting or reduced levels of drinking, according to a
Oncology February 18,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com